Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

CureVac N.V (CVAC) Return on Capital Employed: 2021-2025

Historic Return on Capital Employed for CureVac N.V (CVAC) over the last 3 years, with Jun 2025 value amounting to 0.10%.

  • CureVac N.V's Return on Capital Employed rose 66.00% to 0.10% in Q2 2025 from the same period last year, while for Jun 2025 it was 0.10%, marking a year-over-year increase of 66.00%. This contributed to the annual value of 0.24% for FY2024, which is 69.00% up from last year.
  • CureVac N.V's Return on Capital Employed amounted to 0.10% in Q2 2025, which was up 24.43% from 0.08% recorded in Q1 2025.
  • CureVac N.V's Return on Capital Employed's 5-year high stood at 0.51% during Q3 2024, with a 5-year trough of -0.56% in Q2 2024.
  • For the 3-year period, CureVac N.V's Return on Capital Employed averaged around -0.19%, with its median value being -0.37% (2023).
  • In the last 5 years, CureVac N.V's Return on Capital Employed decreased by 23bps in 2023 and then spiked by 92bps in 2024.
  • Quarterly analysis of 5 years shows CureVac N.V's Return on Capital Employed stood at -0.40% in 2021, then increased by 5bps to -0.35% in 2022, then declined by 8bps to -0.43% in 2023, then spiked by 48bps to 0.04% in 2024, then soared by 66bps to 0.10% in 2025.
  • Its Return on Capital Employed stands at 0.10% for Q2 2025, versus 0.08% for Q1 2025 and 0.04% for Q4 2024.